UBS Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $676K | Buy |
|
|||||
|
2025
Q1 | $401K | Buy |
|
|||||
|
2024
Q4 | $341K | Buy |
|
|||||
|
2024
Q3 | $85K | Buy |
|
|||||
|
2024
Q2 | $30.5K | Sell |
|
|||||
|
2024
Q1 | $107K | Buy |
|
|||||
|
2023
Q4 | $77.2K | Sell |
|
|||||
|
2023
Q3 | $448K | Buy |
|
|||||
|
2023
Q2 | $126K | Sell |
|
|||||
|
2023
Q1 | $471K | Sell |
|
|||||
|
2022
Q4 | $1.86M | Buy |
|
|||||
|
2022
Q3 | $520K | Sell |
|
|||||
|
2022
Q2 | $818K | Sell |
|
|||||
|
2022
Q1 | $2.67M | Buy |
|
|||||
|
2021
Q4 | $3.06M | Buy |
|
|||||
|
2021
Q3 | $2.61M | Buy |
|
|||||
|
2021
Q2 | $1.38M | Sell |
|
|||||
|
2021
Q1 | $4.33M | Buy |
|
|||||
|
2020
Q4 | $607K | Buy |
|
|||||
|
2020
Q3 | $115K | Sell |
|
|||||
|
2020
Q2 | $1.34M | Buy |
|
|||||
|
2020
Q1 | $151K | Buy |
|
|||||
|
2019
Q4 | $147K | Sell |
|
|||||
|
2019
Q3 | $1.59M | Buy |
|
|||||
|
2019
Q2 | $1.06M | Buy |
|
|||||
|
2019
Q1 | $188K | Sell |
|
|||||
|
2018
Q4 | $3.77M | Buy |
|
|||||
|
2018
Q3 | $1.92M | Buy |
|
|||||
|
2018
Q2 | $1.09M | Sell |
|
|||||
|
2018
Q1 | $3.97M | Buy |
|
|||||
|
2017
Q4 | $176K | Sell |
|
|||||
|
2017
Q3 | $200K | Sell |
|
|||||
|
2017
Q2 | $269K | Buy |
|
|||||
|
2017
Q1 | $36K | Sell |
|
|||||
|
2016
Q4 | $56K | Buy |
|
|||||
|
2016
Q3 | $83K | Sell |
|
|||||
|
2016
Q2 | $198K | Buy |
|
|||||
|
2016
Q1 | $81K | Sell |
|
|||||
|
2015
Q4 | $129K | Buy |
|
|||||
|
2015
Q3 | $76K | Sell |
|
|||||
|
2015
Q2 | $192K | Sell |
|
|||||
|
2015
Q1 | $405K | Sell |
|
|||||
|
2014
Q4 | $415K | Buy |
|